KALA BIO, Inc. (KALA) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Arlington, MA, 美国. 现任CEO为 Avi Minkowitz.
KALA 拥有 IPO日期为 2017-07-20, 38 名全职员工, 在 NASDAQ Global Select, 市值为 $4.2M.
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
